Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 693.05 million compared to CNY 783.99 million a year ago. Revenue was CNY 693.73 million compared to CNY 784.82 million a year ago.

Net income was CNY 7.53 million compared to CNY 22.96 million a year ago. Basic earnings per share from continuing operations was CNY 0.0078 compared to CNY 0.0238 a year ago. Diluted earnings per share from continuing operations was CNY 0.0078 compared to CNY 0.0238 a year ago.